Biodesix
BDSX
43 hedge funds and large institutions have $23.2M invested in Biodesix in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
13% more funds holding
Funds holding: 38 → 43 (+5)
0.11% less ownership
Funds ownership: 0.94% → 0.84% (-0.11%)
32% less capital invested
Capital invested by funds: $34.1M → $23.2M (-$10.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
Top Sellers
BDSX Hedge Fund Activity: Q1 2024 in Review
43 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2024, worth a combined $23.2M — down 32% from $34.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new BDSX positions and 5 closed out — a net gain of 6 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was Telemark Asset Management, adding an estimated $2.14M. The largest seller was AIGH Capital Management, cutting an estimated $2.29M.
- 43 institutional investors held Biodesix (BDSX) as of Q1 2024, up from 38 in Q4 2023.
- Funds reported $23.2M of Biodesix stock for Q1 2024, down 32% quarter-over-quarter.
- 11 funds opened new Biodesix positions in Q1 2024 and 5 closed out, a net change of +6 holders.
- The largest Biodesix buyer in Q1 2024 was Telemark Asset Management, an estimated $2.14M added.
- The largest Biodesix seller in Q1 2024 was AIGH Capital Management, an estimated $2.29M sold.
Based on aggregated 13F filings for Q1 2024.